Osaka

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Psoriasis
• Psoriatic arthritis

Running trials

• Active, not recruiting

  A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

  NCT04908189· Phase 3· Bristol-Myers Squibb· Source